Anne White to retire as Executive Vice President and President, Lilly Neuroscience
Indianapolis: Eli Lilly and Company has announced that Anne White, executive vice president and president, Lilly Neuroscience, will be retiring from Lilly after 30 years of service, effective
She will continue to serve in her role and as a member of Lilly's Executive Committee until her retirement date. An internal and external search is underway for her successor.
"Anne's career has been defined by a deep commitment to advancing medicines for some of the most challenging diseases affecting patients globally," said
During her tenure, White has overseen the development, approval, and launch of multiple new medicines and successfully led efforts to reduce drug development timelines across the pipeline and bring new medicines to patients faster. Through her leadership, the company's neuroscience portfolio has expanded to new medicines in neurodegeneration, pain, substance use disorders, and psychiatry.
She is on the board of
Read also: Novo Nordisk Launches Wegovy in South Africa, Ramping Up Obesity Drug Battle with Eli Lilly
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.